Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effective Conversion of Individuals at Risk

NCT05112757 is registered in ClinicalTrials.gov with Philips Electronics Nederland B.V. acting through Philips CTO organization as lead sponsor.

NCT NCT05112757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05112757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effective Conversion of Individuals at Risk
Lead sponsor
Philips Electronics Nederland B.V. acting through Philips CTO organization
Phase
Not applicable
Overall status
Terminated
Start date
February 24, 2022
Completion date
December 8, 2022
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, obstructive sleep apnea